| Trial ID: | L0314 |
| Source ID: | NCT01974245
|
| Associated Drug: |
Cholecalciferol
|
| Title: |
Supplementation With Cholecalciferol in Dialysis Patients
|
| Acronym: |
|
| Status: |
COMPLETED
|
| Study Results: |
YES
|
| Results: |
https://ClinicalTrials.gov/show/NCT01974245/results
|
| Conditions: |
Chronic Kidney Disease
|
| Interventions: |
DRUG: Cholecalciferol|DRUG: Placebo
|
| Outcome Measures: |
Primary: Change From Baseline in Interleukin-6 at 12 Weeks., 12 weeks | Secondary: Change From Baseline in C-reactive Protein at 12 Weeks, 12 weeks | Other: Change From Baseline in Expression in Monocytes of Vitamin D Receptor, α 1-hydroxylase and 24-hydroxylase Enzymes, and Interleukin-6 at 12 Weeks, 12 weeks
|
| Sponsor/Collaborators: |
Sponsor: Federal University of São Paulo | Collaborators: Conselho Nacional de Desenvolvimento Científico e Tecnológico
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
PHASE2
|
| Enrollment: |
55
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (PARTICIPANT)|Primary Purpose: TREATMENT
|
| Start Date: |
2012-07
|
| Completion Date: |
2014-07
|
| Results First Posted: |
2014-12-12
|
| Last Update Posted: |
2025-03-14
|
| Locations: |
Federal University of São Paulo, São Paulo, 04039-000, Brazil
|
| URL: |
https://clinicaltrials.gov/show/NCT01974245
|
